The President visited Polfa Tarchomin S.A.

Poland Andrzej Duda · President of Poland

14 May 2020 · Visit to Polfa Tarchomin S.A · Polfa Tarchomin S.A, Poland

Context
Duda visited the historic Polfa Tarchomin pharmaceutical plant in Warsaw on 14 May 2020 to highlight its modernization and role in Poland's COVID-19 response.
Main themes
Polfa Tarchomin pharmaceutical plant, Polish pharmaceutical industry revival, investment and modernization, antibiotic production, COVID-19 response and disinfectant production, state-owned enterprise development, oncological drug manufacturing, Poland's role in global pharmacy, pharmaceutical research and innovation
Duration
~5 min
17th percentile
Words
643
17th percentile
Sentences
24
13th percentile
Readability
46
50th percentile
Grade
13.4
61st percentile
Syntax
3.42
90th percentile
Vocabulary
2.24
59th percentile

Translated from Polish

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Economic 63%63%
  • Social 17%17%
  • Ceremonial 17%17%
  • Institutional 4%4%
  • Geopolitical 0%0%
  • Technological 0%0%
  • Environmental 0%0%
  • Not in focus 0%

24 sentences in 11 paragraphs

Good morning, esteemed guests!

I warmly welcome the Minister. I welcome the President, and I thank you for the invitation here to Polfa Tarchomin, to the pharmaceutical plant that has the longest history of all pharmaceutical plants in our country. Because Polfa Tarchomin was established as a plant in 1823, and thus has been operating continuously for almost 200 years – exactly 197 years.

In recent decades, it has experienced a deep crisis, but the last few years – and especially the last five years – mark the return of Polfa Tarchomin to a very dynamic game. This involves huge funds that have been directed to revitalize this plant, to make it a significant player in the pharmaceutical market not only in Poland but, above all – because that is what matters most to us – in Europe, and in the future, I hope, also in the global market.

Polfa has a long tradition of producing antibiotics, which are the most highly specialized antibiotics used in hospitals – thus in advanced medicine. Today, it still engages in this. But above all, there are plans to build new lines here. Today, there are 30 lines where over 50 different pharmaceutical preparations are produced.

But these are great plans for the development of the plant, which – as I said – involves 200 million zł that have been allocated in recent years for the capitalization of Polfa Tarchomin; in just the last two years, investments amounting to 48 million zł have been realized; this is primarily about development for the future. And currently, it is one of the foundations of the fight here, in Poland, against the coronavirus.

Because it is no one else but Polfa Tarchomin – alongside Orlen – that received a directive from the Polish government, the Prime Minister, and the Minister of Health to produce disinfectant liquid. And indeed, two very well-known products on the Polish market marked with the code TZF – that is, Tarchomińskie Zakłady Farmaceutyczne – are today widely used, are on sale, and are reaching everywhere they are needed.

Polfa fulfills all orders on an ongoing basis. The plant is developing, and I am very pleased that today I could visit and see this perspective. Because this is a very large area in Warsaw, where many graduates complete their studies every year – both in pharmacy, chemical studies, and various management studies. I believe that for many of them, the future lies precisely in these plants, which at this moment and in the coming years will certainly develop dynamically.

There are great investment plans regarding the construction – which will be carried out here – of modern laboratories at the absolute forefront of the world, where oncological drugs will be produced, and the most advanced pharmaceutical substances in the world will be manufactured. I am glad that the company, which is largely owned by the State Treasury, is returning to the path of dynamic development.

As I said at the beginning: I believe that in the near future it will be a serious player not only in the European market but also in the global market, which will allow Poland to return to its traditional role as a serious player in global pharmacy, also in terms of conducting research and developmental goals in this area, and in innovative industry. I believe that soon we will find ourselves back in the European and global forefront.

I would like to thank the Minister very much, because it is the decisions made by the Polish government that lead to the company being able to develop dynamically today under leadership that not only knows the company well and is deeply connected to its tradition and history but, above all, has great ambitions for the company to once again become a serious player in the world of pharmacy.

Thank you very much.